Search results
Results from the Tech24 Deals Content Network
Abbott Laboratories (NYSE: ABT) Q2 2024 Earnings Call Jul 18, 2024, ... Before you buy stock in Abbott Laboratories, consider this: ... We also reported adjusted earnings per share of $1.14, which ...
Looking into the current session, Abbott Laboratories Inc. (NYSE: ABT) is trading at $106.71, after a 0.69% decrease. Over the past month, the stock decreased by 2.79%, but over the past year, it ...
Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Abbott (ABT) Moves ...
Abbott Laboratories. Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and ...
Abbott (ABT) closed at $118.51 in the latest trading session, marking a +0.83% move from the prior day.
Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Strong performance by the Diabetes Care and Diagnostics businesses is driving the top line for Abbott (ABT).
For premium support please call: 800-290-4726 more ways to reach us